Zobrazeno 1 - 10
of 499
pro vyhledávání: '"Heiwa, Kanamori"'
Autor:
Kaito Harada, Makoto Onizuka, Takehiko Mori, Hiroaki Shimizu, Sachiko Seo, Nobuyuki Aotsuka, Yusuke Takeda, Noritaka Sekiya, Machiko Kusuda, Shinichiro Fujiwara, Sawako Shiraiwa, Katsuhiro Shono, Naoki Shingai, Heiwa Kanamori, Mamiko Momoki, Satoru Takada, Junichi Mukae, Shinichi Masuda, Kinuko Mitani, Emiko Sakaida, Tatsuki Tomikawa, Satoshi Takahashi, Kensuke Usuki, Yoshinobu Kanda
Publikováno v:
International Journal of Infectious Diseases, Vol 131, Iss , Pp 79-86 (2023)
Objectives: Influenza virus infection (IVI) occasionally causes lower respiratory tract infection (LRTI) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Although the progression to LRTI entails a high mortality, the role
Externí odkaz:
https://doaj.org/article/6c3e0d7a11da498db56a870f38832cd2
Autor:
Natsuki Hirose, Takayoshi Tachibana, Akihiko Izumi, Shuku Sato, Noriyuki Tadera, Yotaro Tamai, Heiwa Kanamori, Masatsugu Tanaka, Hideaki Nakajima
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjectives and Methods This single-center retrospective study was performed to evaluate the safety and efficacy of FMS-like tyrosine kinase 3 (FLT3) inhibitors before and after allogeneic hematopoietic cell transplantation (HCT) in relapsed/r
Externí odkaz:
https://doaj.org/article/f91cf94c75a84c5eb87d94b67595d990
Autor:
Haruka Teshigawara-Tanabe, Maki Hagihara, Jun Aoki, Satoshi Koyama, Hiroyuki Takahashi, Yuki Nakajima, Hiroyoshi Kunimoto, Takayoshi Tachibana, Takuya Miyazaki, Kenji Matsumoto, Masatsugu Tanaka, Etsuko Yamazaki, Shin Fujisawa, Heiwa Kanamori, Masataka Taguri, Hideaki Nakajima
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 620-628 (2022)
Objectives: Allogeneic hematopoietic stem cell transplantation (allo-HCT) is the only curative treatment for myelodysplastic syndromes (MDS), although predicting post-transplant outcomes remains inconclusive. This study evaluated patients who underwe
Externí odkaz:
https://doaj.org/article/52c7e0daf709498f9f99e3569e47dd0b
Autor:
Ibuki Harada, Haruka Sasaki, Koichi Murakami, Akira Nishiyama, Jun Nakabayashi, Motohide Ichino, Takuya Miyazaki, Ken Kumagai, Kenji Matsumoto, Maki Hagihara, Wataru Kawase, Takayoshi Tachibana, Masatsugu Tanaka, Tomoyuki Saito, Heiwa Kanamori, Hiroyuki Fujita, Shin Fujisawa, Hideaki Nakajima, Tomohiko Tamura
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Chronic myeloid leukemia (CML) is a form of myeloproliferative neoplasm caused by the oncogenic tyrosine kinase BCR-ABL. Although tyrosine kinase inhibitors have dramatically improved the prognosis of patients with CML, several problems such
Externí odkaz:
https://doaj.org/article/ca1582ae26944192807940863f8aa2cc
Autor:
Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta, Isamu Sugiura, Masashi Sawa, Nobuaki Dobashi, Hisayuki Yokoyama, Noriko Doki, Akihiro Tomita, Toru Kiguchi, Shiro Koh, Heiwa Kanamori, Noriyoshi Iriyama, Akio Kohno, Yukiyoshi Moriuchi, Noboru Asada, Daiki Hirano, Kazuto Togitani, Toru Sakura, Maki Hagihara, Tatsuki Tomikawa, Yasuhisa Yokoyama, Norio Asou, Shigeki Ohtake, Itaru Matsumura, Yasushi Miyazaki, Tomoki Naoe, Hitoshi Kiyoi
Publikováno v:
Blood Advances, Vol 4, Iss 1, Pp 66-75 (2020)
Abstract: The prognostic impact of KIT mutation on core-binding factor acute myeloid leukemia (CBF-AML) remains controversial. We registered 199 newly diagnosed de novo CBF-AML patients, aged 16 to 64 years, who achieved complete remission. They rece
Externí odkaz:
https://doaj.org/article/d8f98219f90f425d95e4fd4f64876f2b
Autor:
Yuho Najima, Takayoshi Tachibana, Yusuke Takeda, Yuya Koda, Yasuhisa Aoyama, Takashi Toya, Aiko Igarashi, Masatsugu Tanaka, Emiko Sakaida, Ryohei Abe, Makoto Onizuka, Takeshi Kobayashi, Noriko Doki, Kazuteru Ohashi, Heiwa Kanamori, Takuma Ishizaki, Akira Yokota, Satoshi Morita, Shinichiro Okamoto, Yoshinobu Kanda
Publikováno v:
Annals of Hematology. 101:2719-2729
This 3+3 dose-escalation phase I multicenter study investigated the optimal dose of azacitidine (AZA) for post-hematopoietic stem cell transplantation (HSCT) maintenance, which remains unknown in Japan. Recipients of a first HSCT for high-risk myelod
Autor:
Takayoshi Tachibana, Masatsugu Tanaka, Maki Hagihara, Katsumichi Fujimaki, Heiwa Kanamori, Hideaki Nakajima
Publikováno v:
International Journal of Hematology. 116:594-602
Outcomes in patients with acute lymphoblastic leukemia (ALL) who experience relapse after allogeneic hematopoietic cell transplantation (HCT) are unsatisfactory. This study aimed to evaluate the outcomes of patients with ALL who underwent second HCT
Autor:
Kazuhiko Ikeda, Keiji Minakawa, Kenichi Yamahara, Minami Yamada‐Fujiwara, Yoshiki Okuyama, Shin‐ichiro Fujiwara, Rie Yamazaki, Heiwa Kanamori, Tohru Iseki, Tokiko Nagamura‐Inoue, Kazuaki Kameda, Kazuhiro Nagai, Nobuharu Fujii, Takashi Ashida, Asao Hirose, Tsutomu Takahashi, Hitoshi Ohto, Koki Ueda, Ryuji Tanosaki
Publikováno v:
Transfusion. 62:1280-1288
The standard cryoprotectant for human cellular products is dimethyl sulfoxide (DMSO), which is associated with hematopoietic cell infusion-related adverse events (HCI-AEs) in hematopoietic stem cell transplantation including peripheral blood stem cel
Autor:
Wataru Yamamoto, Eriko Ogusa, Kenji Matsumoto, Atsuo Maruta, Yoshiaki Ishigatsubo, Heiwa Kanamori
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 3, Pp 196-201 (2016)
Objective: The clinical significance of eosinophilia after allogeneic hematopoietic stem cell transplantation is controversial. This study aimed to retrospectively study the impact of eosinophilia on the outcome of allogeneic hematopoietic stem cell
Externí odkaz:
https://doaj.org/article/36582b3b19aa41c9ac83352a9554c3d0
Autor:
Ayako Mori, Saiko Kurosawa, Takuhiro Yamaguchi, Takehiko Mori, Heiwa Kanamori, Yasushi Onishi, Nobuhiko Emi, Shin Fujisawa, Akio Kohno, Chiaki Nakaseko, Bungo Saito, Tadakazu Kondo, Yukari Umemoto, Yuichiro Nawa, Shunichi Kato, Akiko Hashimoto, Takahiro Fukuda, Kaori Yagasaki
Publikováno v:
Japanese Journal of Transplantation and Cellular Therapy. 11:177-186